SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Pain Management

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128406

Cover Image

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128406

Pain Management Drugs Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 2-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4850
Unprintable PDF & Excel (Multi User License)
USD 5850
PDF, Excel & PPT (Enterprise License)
USD 6850

Add to Cart

Description

Table of Contents

List of Tables

Growth Factors of pain management drugs Market

The global pain management drugs market was valued at USD 74.02 billion in 2025 and is projected to grow from USD 77.58 billion in 2026 to USD 117.18 billion by 2034, registering a CAGR of 5.29% during the forecast period. North America dominated the market in 2025, accounting for 47.59% of the global market share, supported by advanced healthcare infrastructure, high prescription volumes, and increasing adoption of innovative non-opioid pain therapies.

Pain management drugs are used to relieve acute and chronic pain associated with conditions such as arthritis, neuropathic pain, migraine, cancer pain, fibromyalgia, musculoskeletal disorders, and post-operative recovery. Rising prevalence of chronic pain, an aging global population, increasing surgical procedures, and growing awareness of effective pain treatment continue to support market expansion. At the same time, pharmaceutical companies are focusing on developing safer, non-opioid therapies to address concerns surrounding opioid dependence and misuse.

Market Trends

One of the most significant trends shaping the pain management drugs market is the increasing adoption of multimodal pain management strategies. Healthcare providers are combining multiple drug classes-including NSAIDs, acetaminophen, local anesthetics, anticonvulsants, antidepressants, and non-opioid analgesics-to improve pain control while minimizing opioid use.

The growing clinical preference for opioid-sparing therapies has encouraged pharmaceutical companies to invest in innovative products that target multiple pain pathways. In addition, expanding use of localized treatments such as topical gels, patches, and injectable therapies is improving patient outcomes while reducing systemic side effects.

Market Drivers

The major driver of the market is the rising global burden of chronic pain disorders. Conditions including arthritis, chronic back pain, migraine, neuropathic pain, fibromyalgia, and cancer-related pain require long-term treatment, resulting in sustained demand for both prescription and over-the-counter analgesics.

Growing investments in innovative drug development are also fueling market growth. Pharmaceutical companies continue introducing advanced non-opioid medications that provide effective pain relief with improved safety profiles. Rising numbers of surgeries worldwide further increase the need for post-operative pain management products across hospitals and outpatient settings.

Market Restraints

Despite favorable growth prospects, the market faces restraints due to opioid safety concerns and long-term adverse effects associated with certain analgesics. Opioid medications remain highly effective for severe pain but are associated with dependence, misuse, addiction, and overdose risks.

Similarly, prolonged use of NSAIDs may increase cardiovascular and gastrointestinal complications, prompting physicians to adopt more cautious prescribing practices. Regulatory authorities continue strengthening safety guidelines, limiting long-term growth of traditional opioid therapies.

Market Opportunities

The expanding demand for topical and localized pain management therapies presents significant growth opportunities. Products such as pain relief gels, sprays, creams, transdermal patches, and localized non-opioid formulations provide targeted treatment while reducing systemic exposure.

Increasing preference for convenient, non-invasive treatment options among elderly patients and individuals managing multiple chronic conditions is encouraging manufacturers to expand their topical pain relief portfolios. Furthermore, continued development of migraine-specific therapies and next-generation non-opioid analgesics is expected to create new revenue opportunities.

Market Challenges

One of the primary challenges facing the market is the strict regulatory environment surrounding opioid-based medications. Governments and healthcare agencies continue implementing tighter prescribing guidelines, enhanced safety labeling, and monitoring programs to reduce opioid misuse.

Developing safer alternatives requires extensive clinical research, regulatory approval, and significant investment, making product development both time-consuming and costly. Pharmaceutical companies must balance innovation with stringent safety requirements to remain competitive.

Segmentation Analysis

By Drug Class

The NSAIDs segment accounted for the largest market share in 2025 due to their widespread use in treating arthritis, musculoskeletal disorders, back pain, post-operative pain, and other acute pain conditions. Their availability as both prescription and over-the-counter medications continues to support strong global demand.

The anti-migraine drugs segment is projected to record the fastest growth during the forecast period, driven by increasing diagnosis rates, improved awareness, and continued introduction of innovative migraine therapies.

By Pain Type

The chronic pain segment dominated the market in 2025 as long-term conditions such as arthritis, neuropathic pain, migraine, fibromyalgia, chronic back pain, and cancer pain require continuous treatment and repeated prescriptions.

The acute pain segment is expected to witness steady growth, supported by increasing surgical procedures, trauma care, and emergency pain management.

By Drug Type

The prescription drugs segment remained the largest revenue contributor due to the high value of physician-prescribed therapies for chronic pain, migraine, cancer pain, neuropathic disorders, and post-operative recovery.

Meanwhile, OTC pain medications continue to maintain high sales volumes due to their convenience and widespread availability through retail pharmacies.

Regional Outlook

North America led the global market with a valuation of USD 35.23 billion in 2025, supported by strong healthcare spending, high prevalence of chronic pain disorders, and rapid adoption of innovative non-opioid therapies.

Europe remains the second-largest regional market, driven by its aging population, increasing musculoskeletal disorders, and growing preference for safer pain management approaches.

Asia Pacific is expected to witness robust growth as rising healthcare access, expanding pharmaceutical industries, and increasing diagnosis of chronic pain conditions boost demand across China, Japan, India, and other emerging economies. Latin America and the Middle East & Africa are also expected to experience steady growth due to improving healthcare infrastructure and greater availability of pain medications.

Competitive Landscape

The global pain management drugs market is moderately fragmented, with leading pharmaceutical companies competing through extensive product portfolios, continuous research and development, strategic acquisitions, and regulatory approvals for innovative therapies. Increasing investment in non-opioid medicines, migraine treatments, localized pain relief products, and generic drug expansion continues to strengthen market competition.

Major companies operating in the market include AbbVie Inc., Haleon plc, Bayer AG, Kenvue Inc., Pfizer Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sanofi, and Grunenthal GmbH.

Recent industry developments include AbbVie's European Commission approval for AQUIPTA in June 2026, Elite Pharmaceuticals' launch of generic methadone tablets in April 2026, Hikma Pharmaceuticals' generic Nucynta launch in February 2026, and Tonix Pharmaceuticals' commercialization of TONMYA for fibromyalgia in November 2025, reflecting continued innovation across non-opioid and targeted pain therapies.

Conclusion

The pain management drugs market is expected to maintain steady growth as the prevalence of chronic pain conditions continues to rise globally. Increasing demand for safer non-opioid therapies, expanding use of multimodal treatment approaches, growing investments in migraine and neuropathic pain medications, and continuous pharmaceutical innovation will remain the key factors driving industry expansion. With the market projected to increase from USD 74.02 billion in 2025 to USD 117.18 billion by 2034, companies that focus on advanced, targeted, and patient-centered pain management solutions are well positioned to capitalize on future growth opportunities.

Segmentation By Drug Class, Pain Type, Drug Type, Disease Indication, Route of Administration, Age Group, Type, Distribution Channel, and Region

By Drug Class * Opioids

  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Local Anesthetics
  • Anticonvulsants
  • Antidepressants
  • Anti-migraine Drugs
  • Non-opioid/Non-narcotic Analgesics
  • Muscle Relaxants
  • Others

By Pain Type * Acute Pain

  • Chronic Pain

By Drug Type * Prescription

  • OTC

By Disease Indication * Neuropathic Pain

  • Cancer Pain
  • Post-operative Pain
  • Arthritis Pain
  • Chronic Back Pain
  • Migraine
  • Fibromyalgia
  • Others

By Route of Administration * Oral

  • Injectable/Parenteral
  • Transdermal
  • Topical
  • Others

By Age Group * Pediatric

  • Adults

By Type * Branded

  • Generic

By Distribution Channel * Hospital Pharmacies

  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

By Region * North America (By Drug Class, Pain Type, Drug Type, Disease Indication, Route of Administration, Age Group, Type, Distribution Channel, and Country)

    • U.S.
    • Canada
  • Europe (By Drug Class, Pain Type, Drug Type, Disease Indication, Route of Administration, Age Group, Type, Distribution Channel, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Drug Class, Pain Type, Drug Type, Disease Indication, Route of Administration, Age Group, Type, Distribution Channel, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Drug Class, Pain Type, Drug Type, Disease Indication, Route of Administration, Age Group, Type, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Drug Class, Pain Type, Drug Type, Disease Indication, Route of Administration, Age Group, Type, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
Show more
Product Code: FBI117454

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Regions/ Countries
  • 4.2. New Product Launches, By Key Players
  • 4.3. Overview of Regulatory Scenario, By Key Regions/ Countries
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, and Others)

5. Global Pain Management Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Drug Class
    • 5.1.1. Opioids
    • 5.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • 5.1.3. Local Anesthetics
    • 5.1.4. Anticonvulsants
    • 5.1.5. Antidepressants
    • 5.1.6. Anti-migraine Drugs
    • 5.1.7. Non-opioid/Non-narcotic Analgesics
    • 5.1.8. Muscle Relaxants
    • 5.1.9. Others
  • 5.2. Market Analysis, Insights and Forecast - By Pain Type
    • 5.2.1. Acute Pain
    • 5.2.2. Chronic Pain
  • 5.3. Market Analysis, Insights and Forecast - By Drug Type
    • 5.3.1. Prescription
    • 5.3.2. OTC
  • 5.4. Market Analysis, Insights and Forecast - By Disease Indication
    • 5.4.1. Neuropathic Pain
    • 5.4.2. Cancer Pain
    • 5.4.3. Post-operative Pain
    • 5.4.4. Arthritis Pain
    • 5.4.5. Chronic Back Pain
    • 5.4.6. Migraine
    • 5.4.7. Fibromyalgia
    • 5.4.8. Others
  • 5.5. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.5.1. Oral
    • 5.5.2. Injectable/Parenteral
    • 5.5.3. Transdermal
    • 5.5.4. Topical
    • 5.5.5. Others
  • 5.6. Market Analysis, Insights and Forecast - By Age Group
    • 5.6.1. Pediatric
    • 5.6.2. Adults
  • 5.7. Market Analysis, Insights and Forecast - By Type
    • 5.7.1. Branded
    • 5.7.2. Generic
  • 5.8. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.8.1. Hospital Pharmacies
    • 5.8.2. Drug Stores & Retail Pharmacies
    • 5.8.3. Online Pharmacies
  • 5.9. Market Analysis, Insights and Forecast - Region
    • 5.9.1. North America
    • 5.9.2. Europe
    • 5.9.3. Asia Pacific
    • 5.9.4. Latin America
    • 5.9.5. Middle East & Africa

6. North America Pain Management Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Drug Class
    • 6.1.1. Opioids
    • 6.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • 6.1.3. Local Anesthetics
    • 6.1.4. Anticonvulsants
    • 6.1.5. Antidepressants
    • 6.1.6. Anti-migraine Drugs
    • 6.1.7. Non-opioid/Non-narcotic Analgesics
    • 6.1.8. Muscle Relaxants
    • 6.1.9. Others
  • 6.2. Market Analysis, Insights and Forecast - By Pain Type
    • 6.2.1. Acute Pain
    • 6.2.2. Chronic Pain
  • 6.3. Market Analysis, Insights and Forecast - By Drug Type
    • 6.3.1. Prescription
    • 6.3.2. OTC
  • 6.4. Market Analysis, Insights and Forecast - By Disease Indication
    • 6.4.1. Neuropathic Pain
    • 6.4.2. Cancer Pain
    • 6.4.3. Post-operative Pain
    • 6.4.4. Arthritis Pain
    • 6.4.5. Chronic Back Pain
    • 6.4.6. Migraine
    • 6.4.7. Fibromyalgia
    • 6.4.8. Others
  • 6.5. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.5.1. Oral
    • 6.5.2. Injectable/Parenteral
    • 6.5.3. Transdermal
    • 6.5.4. Topical
    • 6.5.5. Others
  • 6.6. Market Analysis, Insights and Forecast - By Age Group
    • 6.6.1. Pediatric
    • 6.6.2. Adults
  • 6.7. Market Analysis, Insights and Forecast - By Type
    • 6.7.1. Branded
    • 6.7.2. Generic
  • 6.8. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.8.1. Hospital Pharmacies
    • 6.8.2. Drug Stores & Retail Pharmacies
    • 6.8.3. Online Pharmacies
  • 6.9. Market Analysis, Insights and Forecast - By Country
    • 6.9.1. U.S.
    • 6.9.2. Canada

7. Europe Pain Management Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Drug Class
    • 7.1.1. Opioids
    • 7.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • 7.1.3. Local Anesthetics
    • 7.1.4. Anticonvulsants
    • 7.1.5. Antidepressants
    • 7.1.6. Anti-migraine Drugs
    • 7.1.7. Non-opioid/Non-narcotic Analgesics
    • 7.1.8. Muscle Relaxants
    • 7.1.9. Others
  • 7.2. Market Analysis, Insights and Forecast - By Pain Type
    • 7.2.1. Acute Pain
    • 7.2.2. Chronic Pain
  • 7.3. Market Analysis, Insights and Forecast - By Drug Type
    • 7.3.1. Prescription
    • 7.3.2. OTC
  • 7.4. Market Analysis, Insights and Forecast - By Disease Indication
    • 7.4.1. Neuropathic Pain
    • 7.4.2. Cancer Pain
    • 7.4.3. Post-operative Pain
    • 7.4.4. Arthritis Pain
    • 7.4.5. Chronic Back Pain
    • 7.4.6. Migraine
    • 7.4.7. Fibromyalgia
    • 7.4.8. Others
  • 7.5. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.5.1. Oral
    • 7.5.2. Injectable/Parenteral
    • 7.5.3. Transdermal
    • 7.5.4. Topical
    • 7.5.5. Others
  • 7.6. Market Analysis, Insights and Forecast - By Age Group
    • 7.6.1. Pediatric
    • 7.6.2. Adults
  • 7.7. Market Analysis, Insights and Forecast - By Type
    • 7.7.1. Branded
    • 7.7.2. Generic
  • 7.8. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.8.1. Hospital Pharmacies
    • 7.8.2. Drug Stores & Retail Pharmacies
    • 7.8.3. Online Pharmacies
  • 7.9. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.9.1. U.K.
    • 7.9.2. Germany
    • 7.9.3. France
    • 7.9.4. Italy
    • 7.9.5. Spain
    • 7.9.6. Scandinavia
    • 7.9.7. Rest of Europe

8. Asia Pacific Pain Management Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Drug Class
    • 8.1.1. Opioids
    • 8.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • 8.1.3. Local Anesthetics
    • 8.1.4. Anticonvulsants
    • 8.1.5. Antidepressants
    • 8.1.6. Anti-migraine Drugs
    • 8.1.7. Non-opioid/Non-narcotic Analgesics
    • 8.1.8. Muscle Relaxants
    • 8.1.9. Others
  • 8.2. Market Analysis, Insights and Forecast - By Pain Type
    • 8.2.1. Acute Pain
    • 8.2.2. Chronic Pain
  • 8.3. Market Analysis, Insights and Forecast - By Drug Type
    • 8.3.1. Prescription
    • 8.3.2. OTC
  • 8.4. Market Analysis, Insights and Forecast - By Disease Indication
    • 8.4.1. Neuropathic Pain
    • 8.4.2. Cancer Pain
    • 8.4.3. Post-operative Pain
    • 8.4.4. Arthritis Pain
    • 8.4.5. Chronic Back Pain
    • 8.4.6. Migraine
    • 8.4.7. Fibromyalgia
    • 8.4.8. Others
  • 8.5. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.5.1. Oral
    • 8.5.2. Injectable/Parenteral
    • 8.5.3. Transdermal
    • 8.5.4. Topical
    • 8.5.5. Others
  • 8.6. Market Analysis, Insights and Forecast - By Age Group
    • 8.6.1. Pediatric
    • 8.6.2. Adults
  • 8.7. Market Analysis, Insights and Forecast - By Type
    • 8.7.1. Branded
    • 8.7.2. Generic
  • 8.8. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.8.1. Hospital Pharmacies
    • 8.8.2. Drug Stores & Retail Pharmacies
    • 8.8.3. Online Pharmacies
  • 8.9. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.9.1. China
    • 8.9.2. Japan
    • 8.9.3. India
    • 8.9.4. Southeast Asia
    • 8.9.5. Australia
    • 8.9.6. Rest of Asia Pacific

9. Latin America Pain Management Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Drug Class
    • 9.1.1. Opioids
    • 9.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • 9.1.3. Local Anesthetics
    • 9.1.4. Anticonvulsants
    • 9.1.5. Antidepressants
    • 9.1.6. Anti-migraine Drugs
    • 9.1.7. Non-opioid/Non-narcotic Analgesics
    • 9.1.8. Muscle Relaxants
    • 9.1.9. Others
  • 9.2. Market Analysis, Insights and Forecast - By Pain Type
    • 9.2.1. Acute Pain
    • 9.2.2. Chronic Pain
  • 9.3. Market Analysis, Insights and Forecast - By Drug Type
    • 9.3.1. Prescription
    • 9.3.2. OTC
  • 9.4. Market Analysis, Insights and Forecast - By Disease Indication
    • 9.4.1. Neuropathic Pain
    • 9.4.2. Cancer Pain
    • 9.4.3. Post-operative Pain
    • 9.4.4. Arthritis Pain
    • 9.4.5. Chronic Back Pain
    • 9.4.6. Migraine
    • 9.4.7. Fibromyalgia
    • 9.4.8. Others
  • 9.5. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.5.1. Oral
    • 9.5.2. Injectable/Parenteral
    • 9.5.3. Transdermal
    • 9.5.4. Topical
    • 9.5.5. Others
  • 9.6. Market Analysis, Insights and Forecast - By Age Group
    • 9.6.1. Pediatric
    • 9.6.2. Adults
  • 9.7. Market Analysis, Insights and Forecast - By Type
    • 9.7.1. Branded
    • 9.7.2. Generic
  • 9.8. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.8.1. Hospital Pharmacies
    • 9.8.2. Drug Stores & Retail Pharmacies
    • 9.8.3. Online Pharmacies
  • 9.9. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.9.1. Brazil
    • 9.9.2. Mexico
    • 9.9.3. Rest of Latin America

10. Middle East & Africa Pain Management Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Drug Class
    • 10.1.1. Opioids
    • 10.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • 10.1.3. Local Anesthetics
    • 10.1.4. Anticonvulsants
    • 10.1.5. Antidepressants
    • 10.1.6. Anti-migraine Drugs
    • 10.1.7. Non-opioid/Non-narcotic Analgesics
    • 10.1.8. Muscle Relaxants
    • 10.1.9. Others
  • 10.2. Market Analysis, Insights and Forecast - By Pain Type
    • 10.2.1. Acute Pain
    • 10.2.2. Chronic Pain
  • 10.3. Market Analysis, Insights and Forecast - By Drug Type
    • 10.3.1. Prescription
    • 10.3.2. OTC
  • 10.4. Market Analysis, Insights and Forecast - By Disease Indication
    • 10.4.1. Neuropathic Pain
    • 10.4.2. Cancer Pain
    • 10.4.3. Post-operative Pain
    • 10.4.4. Arthritis Pain
    • 10.4.5. Chronic Back Pain
    • 10.4.6. Migraine
    • 10.4.7. Fibromyalgia
    • 10.4.8. Others
  • 10.5. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.5.1. Oral
    • 10.5.2. Injectable/Parenteral
    • 10.5.3. Transdermal
    • 10.5.4. Topical
    • 10.5.5. Others
  • 10.6. Market Analysis, Insights and Forecast - By Age Group
    • 10.6.1. Pediatric
    • 10.6.2. Adults
  • 10.7. Market Analysis, Insights and Forecast - By Type
    • 10.7.1. Branded
    • 10.7.2. Generic
  • 10.8. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.8.1. Hospital Pharmacies
    • 10.8.2. Drug Stores & Retail Pharmacies
    • 10.8.3. Online Pharmacies
  • 10.9. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.9.1. GCC
    • 10.9.2. South Africa
    • 10.9.3. Rest of the Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc.
    • 11.2.2. Haleon plc
    • 11.2.3. Bayer AG
    • 11.2.4. Kenvue Inc.
    • 11.2.5. Pfizer Inc.
    • 11.2.6. Eli Lilly and Company
    • 11.2.7. Teva Pharmaceutical Industries Ltd.
    • 11.2.8. Viatris Inc.
    • 11.2.9. Sanofi
    • 11.2.10. Grunenthal GmbH
Show more
Product Code: FBI117454

List of Tables

  • Table 1: Global Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034
  • Table 2: Global Pain Management Drugs Market Revenue (USD Billion) Forecast, by Pain Type, 2021-2034
  • Table 3: Global Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Type, 2021-2034
  • Table 4: Global Pain Management Drugs Market Revenue (USD Billion) Forecast, by Disease Indication, 2021-2034
  • Table 5: Global Pain Management Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034
  • Table 6: Global Pain Management Drugs Market Revenue (USD Billion) Forecast, by Age Group, 2021-2034
  • Table 7: Global Pain Management Drugs Market Revenue (USD Billion) Forecast, by Type, 2021-2034
  • Table 8: Global Pain Management Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034
  • Table 9: Global Pain Management Drugs Market Revenue (USD Billion) Forecast, by Region, 2021-2034
  • Table 10: North America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034
  • Table 11: North America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Pain Type, 2021-2034
  • Table 12: North America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Type, 2021-2034
  • Table 13: North America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Disease Indication, 2021-2034
  • Table 14: North America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034
  • Table 15: North America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Age Group, 2021-2034
  • Table 16: North America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Type, 2021-2034
  • Table 17: North America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034
  • Table 18: North America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Country, 2021-2034
  • Table 19: Europe Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034
  • Table 20: Europe Pain Management Drugs Market Revenue (USD Billion) Forecast, by Pain Type, 2021-2034
  • Table 21: Europe Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Type, 2021-2034
  • Table 22: Europe Pain Management Drugs Market Revenue (USD Billion) Forecast, by Disease Indication, 2021-2034
  • Table 23: Europe Pain Management Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034
  • Table 24: Europe Pain Management Drugs Market Revenue (USD Billion) Forecast, by Age Group, 2021-2034
  • Table 25: Europe Pain Management Drugs Market Revenue (USD Billion) Forecast, by Type, 2021-2034
  • Table 26: Europe Pain Management Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034
  • Table 27: Europe Pain Management Drugs Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 28: Asia Pacific Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034
  • Table 29: Asia Pacific Pain Management Drugs Market Revenue (USD Billion) Forecast, by Pain Type, 2021-2034
  • Table 30: Asia Pacific Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Type, 2021-2034
  • Table 31: Asia Pacific Pain Management Drugs Market Revenue (USD Billion) Forecast, by Disease Indication, 2021-2034
  • Table 32: Asia Pacific Pain Management Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034
  • Table 33: Asia Pacific Pain Management Drugs Market Revenue (USD Billion) Forecast, by Age Group, 2021-2034
  • Table 34: Asia Pacific Pain Management Drugs Market Revenue (USD Billion) Forecast, by Type, 2021-2034
  • Table 35: Asia Pacific Pain Management Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034
  • Table 36: Asia Pacific Pain Management Drugs Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 37: Latin America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034
  • Table 38: Latin America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Pain Type, 2021-2034
  • Table 39: Latin America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Type, 2021-2034
  • Table 40: Latin America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Disease Indication, 2021-2034
  • Table 41: Latin America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034
  • Table 42: Latin America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Age Group, 2021-2034
  • Table 43: Latin America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Type, 2021-2034
  • Table 44: Latin America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034
  • Table 45: Latin America Pain Management Drugs Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 46: Middle East & Africa Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034
  • Table 47: Middle East & Africa Pain Management Drugs Market Revenue (USD Billion) Forecast, by Pain Type, 2021-2034
  • Table 48: Middle East & Africa Pain Management Drugs Market Revenue (USD Billion) Forecast, by Drug Type, 2021-2034
  • Table 49: Middle East & Africa Pain Management Drugs Market Revenue (USD Billion) Forecast, by Disease Indication, 2021-2034
  • Table 50: Middle East & Africa Pain Management Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034
  • Table 51: Middle East & Africa Pain Management Drugs Market Revenue (USD Billion) Forecast, by Age Group, 2021-2034
  • Table 52: Middle East & Africa Pain Management Drugs Market Revenue (USD Billion) Forecast, by Type, 2021-2034
  • Table 53: Middle East & Africa Pain Management Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034
  • Table 54: Middle East & Africa Pain Management Drugs Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Pain Management Drugs Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
  • Figure 2: Global Pain Management Drugs Market Value Share (%), by Drug Class, 2025 & 2034
  • Figure 3: Global Pain Management Drugs Market Value Share (%), by Pain Type, 2025 & 2034
  • Figure 4: Global Pain Management Drugs Market Value Share (%), by Drug Type, 2025 & 2034
  • Figure 5: Global Pain Management Drugs Market Value Share (%), by Disease Indication, 2025 & 2034
  • Figure 6: Global Pain Management Drugs Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 7: Global Pain Management Drugs Market Value Share (%), by Age Group, 2025 & 2034
  • Figure 8: Global Pain Management Drugs Market Value Share (%), by Type, 2025 & 2034
  • Figure 9: Global Pain Management Drugs Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 10: Global Pain Management Drugs Market Value Share (%), by Region, 2025 & 2034
  • Figure 11: North America Pain Management Drugs Market Value (USD Billion), by Drug Class, 2025 & 2034
  • Figure 12: North America Pain Management Drugs Market Value Share (%), by Drug Class, 2025
  • Figure 13: North America Pain Management Drugs Market Value (USD Billion), by Pain Type, 2025 & 2034
  • Figure 14: North America Pain Management Drugs Market Value Share (%), by Pain Type, 2025
  • Figure 15: North America Pain Management Drugs Market Value (USD Billion), by Drug Type, 2025 & 2034
  • Figure 16: North America Pain Management Drugs Market Value Share (%), by Drug Type, 2025
  • Figure 17: North America Pain Management Drugs Market Value (USD Billion), by Disease Indication, 2025 & 2034
  • Figure 18: North America Pain Management Drugs Market Value Share (%), by Disease Indication, 2025
  • Figure 19: North America Pain Management Drugs Market Value (USD Billion), by Route of Administration, 2025 & 2034
  • Figure 20: North America Pain Management Drugs Market Value Share (%), by Route of Administration, 2025
  • Figure 21: North America Pain Management Drugs Market Value (USD Billion), by Age Group, 2025 & 2034
  • Figure 22: North America Pain Management Drugs Market Value Share (%), by Age Group 2025
  • Figure 23: North America Pain Management Drugs Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 24: North America Pain Management Drugs Market Value Share (%), by Type, 2025
  • Figure 25: North America Pain Management Drugs Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 26: North America Pain Management Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 27: North America Pain Management Drugs Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 28: North America Pain Management Drugs Market Value Share (%), by Country, 2025
  • Figure 29: Europe Pain Management Drugs Market Value (USD Billion), by Drug Class, 2025 & 2034
  • Figure 30: Europe Pain Management Drugs Market Value Share (%), by Drug Class, 2025
  • Figure 31: Europe Pain Management Drugs Market Value (USD Billion), by Pain Type, 2025 & 2034
  • Figure 32: Europe Pain Management Drugs Market Value Share (%), by Pain Type, 2025
  • Figure 33: Europe Pain Management Drugs Market Value (USD Billion), by Drug Type, 2025 & 2034
  • Figure 34: Europe Pain Management Drugs Market Value Share (%), by Drug Type, 2025
  • Figure 35: Europe Pain Management Drugs Market Value (USD Billion), by Disease Indication, 2025 & 2034
  • Figure 36: Europe Pain Management Drugs Market Value Share (%), by Disease Indication, 2025
  • Figure 37: Europe Pain Management Drugs Market Value (USD Billion), by Route of Administration, 2025 & 2034
  • Figure 38: Europe Pain Management Drugs Market Value Share (%), by Route of Administration, 2025
  • Figure 39: Europe Pain Management Drugs Market Value (USD Billion), by Age Group, 2025 & 2034
  • Figure 40: Europe Pain Management Drugs Market Value Share (%), by Age Group, 2025
  • Figure 41: Europe Pain Management Drugs Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 42: Europe Pain Management Drugs Market Value Share (%), by Type, 2025
  • Figure 43: Europe Pain Management Drugs Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Europe Pain Management Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Europe Pain Management Drugs Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 46: Europe Pain Management Drugs Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 47: Asia Pacific Pain Management Drugs Market Value (USD Billion), by Drug Class, 2025 & 2034
  • Figure 48: Asia Pacific Pain Management Drugs Market Value Share (%), by Drug Class, 2025
  • Figure 49: Asia Pacific Pain Management Drugs Market Value (USD Billion), by Pain Type, 2025 & 2034
  • Figure 50: Asia Pacific Pain Management Drugs Market Value Share (%), by Pain Type, 2025
  • Figure 51: Asia Pacific Pain Management Drugs Market Value (USD Billion), by Drug Type, 2025 & 2034
  • Figure 52: Asia Pacific Pain Management Drugs Market Value Share (%), by Drug Type, 2025
  • Figure 53: Asia Pacific Pain Management Drugs Market Value (USD Billion), by Disease Indication, 2025 & 2034
  • Figure 54: Asia Pacific Pain Management Drugs Market Value Share (%), by Disease Indication, 2025
  • Figure 55: Asia Pacific Pain Management Drugs Market Value (USD Billion), by Route of Administration, 2025 & 2034
  • Figure 56: Asia Pacific Pain Management Drugs Market Value Share (%), by Route of Administration, 2025
  • Figure 57: Asia Pacific Pain Management Drugs Market Value (USD Billion), by Age Group, 2025 & 2034
  • Figure 58: Asia Pacific Pain Management Drugs Market Value Share (%), by Age Group, 2025
  • Figure 59: Asia Pacific Pain Management Drugs Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 60: Asia Pacific Pain Management Drugs Market Value Share (%), by Type, 2025
  • Figure 61: Asia Pacific Pain Management Drugs Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 62: Asia Pacific Pain Management Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 63: Asia Pacific Pain Management Drugs Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 64: Asia Pacific Pain Management Drugs Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 65: Latin America Pain Management Drugs Market Value (USD Billion), by Drug Class, 2025 & 2034
  • Figure 66: Latin America Pain Management Drugs Market Value Share (%), by Drug Class, 2025
  • Figure 67: Latin America Pain Management Drugs Market Value (USD Billion), by Pain Type, 2025 & 2034
  • Figure 68: Latin America Pain Management Drugs Market Value Share (%), by Pain Type, 2025
  • Figure 69: Latin America Pain Management Drugs Market Value (USD Billion), by Drug Type, 2025 & 2034
  • Figure 70: Latin America Pain Management Drugs Market Value Share (%), by Drug Type, 2025
  • Figure 71: Latin America Pain Management Drugs Market Value (USD Billion), by Disease Indication, 2025 & 2034
  • Figure 72: Latin America Pain Management Drugs Market Value Share (%), by Disease Indication, 2025
  • Figure 73: Latin America Pain Management Drugs Market Value (USD Billion), by Route of Administration, 2025 & 2034
  • Figure 74: Latin America Pain Management Drugs Market Value Share (%), by Route of Administration, 2025
  • Figure 75: Latin America Pain Management Drugs Market Value (USD Billion), by Age Group, 2025 & 2034
  • Figure 76: Latin America Pain Management Drugs Market Value Share (%), by Age Group, 2025
  • Figure 77: Latin America Pain Management Drugs Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 78: Latin America Pain Management Drugs Market Value Share (%), by Type, 2025
  • Figure 79: Latin America Pain Management Drugs Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 80: Latin America Pain Management Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 81: Latin America Pain Management Drugs Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 82: Latin America Pain Management Drugs Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 83: Middle East & Africa Pain Management Drugs Market Value (USD Billion), by Drug Class, 2025 & 2034
  • Figure 84: Middle East & Africa Pain Management Drugs Market Value Share (%), by Drug Class, 2025
  • Figure 85: Middle East & Africa Pain Management Drugs Market Value (USD Billion), by Pain Type, 2025 & 2034
  • Figure 86: Middle East & Africa Pain Management Drugs Market Value Share (%), by Pain Type, 2025
  • Figure 87: Middle East & Africa Pain Management Drugs Market Value (USD Billion), by Drug Type, 2025 & 2034
  • Figure 88: Middle East & Africa Pain Management Drugs Market Value Share (%), by Drug Type, 2025
  • Figure 89: Middle East & Africa Pain Management Drugs Market Value (USD Billion), by Disease Indication, 2025 & 2034
  • Figure 90: Middle East & Africa Pain Management Drugs Market Value Share (%), by Disease Indication, 2025
  • Figure 91: Middle East & Africa Pain Management Drugs Market Value (USD Billion), by Route of Administration, 2025 & 2034
  • Figure 92: Middle East & Africa Pain Management Drugs Market Value Share (%), by Route of Administration, 2025
  • Figure 93: Middle East & Africa Pain Management Drugs Market Value (USD Billion), by Age Group, 2025 & 2034
  • Figure 94: Middle East & Africa Pain Management Drugs Market Value Share (%), by Age Group, 2025
  • Figure 95: Middle East & Africa Pain Management Drugs Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 96: Middle East & Africa Pain Management Drugs Market Value Share (%), by Type, 2025
  • Figure 97: Middle East & Africa Pain Management Drugs Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 98: Middle East & Africa Pain Management Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 99: Middle East & Africa Pain Management Drugs Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 100: Middle East & Africa Pain Management Drugs Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 101: Global Pain Management Drugs Market Share (%), by Company, 2025
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!